| Myriad Genetics Inc.announced 24 Feb 2025 |
Launch the first AI-driven prostate cancer test due after leader left |
Not met31 Dec 2025 |
| Myriad Genetics Inc.announced 27 Feb 2024 |
Launch new products including Foresight Universal Plus, FirstGene, Precise Tumor, Precise Liquid, and Precise MRD |
Met31 Mar 2025 |
| Myriad Genetics Inc.announced 16 Jan 2024 |
Launch Foresight Universal Plus |
Met31 Dec 2024 |
| Myriad Genetics Inc.announced 16 Jan 2024 |
Transition Salt Lake City Research Park products to new campus |
Being checked31 Dec 2024 |
| Myriad Genetics Inc.announced 16 Jan 2024 |
Launch FirstGene |
Late31 Dec 2024 |
| Myriad Genetics Inc.announced 16 Jan 2024 |
Shift MyChoice products to advanced sequencing |
Being checked31 Dec 2024 |
| Myriad Genetics Inc.announced 16 Jan 2024 |
Fully automate Prenatal labs due after leader left |
Late31 Dec 2025 |
| Myriad Genetics Inc.announced 16 Jan 2024 |
Launch Prolaris Post-RP due after leader left |
Late31 Dec 2025 |
| Myriad Genetics Inc.announced 16 Jan 2024 |
Publish 3-yr Metastasis study due after leader left |
Met31 Dec 2025 |
| Myriad Genetics Inc.announced 6 Nov 2023 |
Publish additional data and detail from the GeneSight study |
Late31 Dec 2024 |
| Myriad Genetics Inc.announced 28 Feb 2023 |
Complete new facility construction and related developments |
Met31 Dec 2023 |
| Myriad Genetics Inc.announced 28 Feb 2023 |
Roll out Epic EMR integration |
Met31 Dec 2023 |
| Myriad Genetics Inc.announced 28 Feb 2023 |
Introduce new products including Precise Liquid and FirstGene |
Not met31 Dec 2023 |
| Myriad Genetics Inc.announced 4 Aug 2022 |
Launch the Precise liquid biopsy offering |
Not met31 Dec 2023 |
| Myriad Genetics Inc.announced 5 May 2022 |
Begin construction of the new research and innovation center in South San Francisco |
Being checked31 Aug 2022 |
| Myriad Genetics Inc.announced 5 May 2022 |
Roll out the Unified Provider Ordering Portal in the Women's Health business unit |
Not met30 Sep 2022 |
| Myriad Genetics Inc.announced 11 Jan 2022 |
Launch Precise Oncology Solutions and Precise Tumor |
Met31 Mar 2022 |
| Myriad Genetics Inc.announced 11 Jan 2022 |
Launch a version of the GeneSight test for women with postpartum depression |
Not met31 Dec 2023 |
| Myriad Genetics Inc.announced 2 Nov 2021 |
Launch a novel prenatal test combining Prequel and Foresight clinical value |
Late31 Dec 2022 |
| Myriad Genetics Inc.announced 23 Feb 2021 |
Submit a new Medicare application based on post-RP patient data |
No record found31 Dec 2021 |